189 related articles for article (PubMed ID: 29197319)
1. Editorial: Multi-target Drug Discovery - Part II.
Chen JN
Curr Top Med Chem; 2017 Nov; 17(28):3081-3083. PubMed ID: 29197319
[No Abstract] [Full Text] [Related]
2. Anti-Inflammatory and Pro-Resolving Effects of N-3 PUFA in Cancers: Structures and Mechanisms.
Wang Q; Hu M; Xu H; Yang X
Curr Top Med Chem; 2016; 16(8):888-94. PubMed ID: 26311422
[TBL] [Abstract][Full Text] [Related]
3. Editorial: Hybrid Compounds as Multitarget Agents in Medicinal Chemistry - Part I.
Scotti L; Mendonca-Junior FJ; Scotti MT
Curr Top Med Chem; 2017; 17(8):843-844. PubMed ID: 28406078
[No Abstract] [Full Text] [Related]
4. Cytotoxic and anti-inflammatory disulfide compounds from the fruiting bodies of Boletus pseudocalopus.
Kim CS; Moon E; Choi SU; Kim SY; Lee KR; Kim KH
J Antibiot (Tokyo); 2015 Jun; 68(6):414-6. PubMed ID: 25627016
[No Abstract] [Full Text] [Related]
5. Hunter-killer peptide (HKP) for targeted therapy.
Ellerby HM; Bredesen DE; Fujimura S; John V
J Med Chem; 2008 Oct; 51(19):5887-92. PubMed ID: 18828573
[No Abstract] [Full Text] [Related]
6. Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease.
Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2016 Jan; 107():63-81. PubMed ID: 26562543
[TBL] [Abstract][Full Text] [Related]
7. Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.
Gao Y; Shen JK; Milane L; Hornicek FJ; Amiji MM; Duan Z
Curr Med Chem; 2015; 22(11):1335-47. PubMed ID: 25666804
[TBL] [Abstract][Full Text] [Related]
8. Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick.
Suthar SK; Sharma M
Mini Rev Med Chem; 2016; 16(15):1201-1218. PubMed ID: 27121716
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Discovery and biosynthesis of natural products with anti-cancer activities.
Deng H
Anticancer Agents Med Chem; 2015; 15(3):276. PubMed ID: 25801124
[No Abstract] [Full Text] [Related]
10. Editorial: Bioactive Small Molecules in Regulating Inflammation and Metabolic Disorder.
Liu Q; Yang X; Chang RC
Curr Top Med Chem; 2016; 16(8):809-10. PubMed ID: 26381415
[No Abstract] [Full Text] [Related]
11. A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs.
Liu J; Wu Y; Piao H; Zhao X; Zhang W; Wang Y; Liu M
Mini Rev Med Chem; 2018; 18(11):948-961. PubMed ID: 27697041
[TBL] [Abstract][Full Text] [Related]
12. Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy - (Part-I).
Thakur SS
Curr Top Med Chem; 2018; 18(30):2543. PubMed ID: 30793675
[No Abstract] [Full Text] [Related]
13. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification.
Li QS; Li Y; Deora GS; Ruan BF
Mini Rev Med Chem; 2019; 19(10):809-825. PubMed ID: 30686253
[TBL] [Abstract][Full Text] [Related]
14. Network-based Drug Discovery, Anti-cancer Molecular Targets and Therapeutic use of Phytochemicals.
Koiri RK; Mehrotra A
Anticancer Agents Med Chem; 2018; 18(13):1794-1795. PubMed ID: 30821217
[No Abstract] [Full Text] [Related]
15. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
[TBL] [Abstract][Full Text] [Related]
16. Overcoming cancer resistance.
Cook KL; Clarke R
Future Med Chem; 2015 Aug; 7(12):1471. PubMed ID: 26334204
[No Abstract] [Full Text] [Related]
17. Challenges in the Discovery of Novel Therapeutic Agents in Cancer.
Nagaraju GP; Kamal MA
Curr Drug Metab; 2019; 20(13):1004-1005. PubMed ID: 32072882
[No Abstract] [Full Text] [Related]
18. Targeting autophagy to overcome drug resistance in cancer therapy.
Kumar A; Singh UK; Chaudhary A
Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
[TBL] [Abstract][Full Text] [Related]
19. Editorial overview: cancer: from target discovery to targeted therapy: the risky business of target validation.
Cruzalegui F
Curr Opin Pharmacol; 2014 Aug; 17():iv-vi. PubMed ID: 25220882
[No Abstract] [Full Text] [Related]
20. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
